Human pluripotent cells hold great promise for numerous biomedical applications including eventual use in regenerative medicine and personalized therapies. However, achieving this important goal requires a better understanding of the regulatory circuitry that establishes and maintains molecular and functional pluripotency. Our previous proposal has provided many profound new insights, data sets and tools for the scientific community. We characterized transcription factor and epigenome dynamics, uncovered hundreds of new non-coding DNA and long non-coding RNA (lncRNA) elements and began to assemble a comprehensive, multi-layered pluripotent gene regulatory network. Through advancements in technology, experimental systems and computational analysis we are now uniquely poised to take the next leap forward in ?Dissecting the establishment and regulation of human pluripotency?. Our current objective is to leverage these latest biological, experimental and computational advances to close important gaps and provide a comprehensive, functional characterization of the regulatory landscape and hierarchies in pluripotent stem cells as well as their dynamics during reprogramming. Specifically we will focus on the following pressing questions that have arisen over the past years: 1) What is the exact nature of the pluripotent state(s) (Projects 1-3)? We already a comprehensive catalogue of the regulatory elements and defining features to will help distinguish these states and will complete these at unprecedented resolution. Why does the nave state emerge only transiently during human reprogramming (Project 1 and 3)? What are the implications of deregulating the pluripotent network including its cis regulatory elements (Project 3)? What is the contribution of genetic variation and coding/non-coding transcription (Project 2 and 3)? 2) How is the pluripotent genome organized in three-dimensional space to establish pluripotency gene- expression programs (Project 1-3)? It is becoming clear that lncRNAs can bind and influence the organization of chromatin within the nucleus.
We aim to understand molecular underpinnings of how RNA (Project 2), DNA (Project 3) and epigenetic/transcription factors (Project 1) establish the nuclear architecture of the pluripotent genome. We will develop novel visualization and genomic technologies in living and fixed cells to chart the dynamic of reorganizing these factors (Project 2) and their functional implications in the process of reprograming as well as during the maintenance of pluripotency (Project 1, 2 and 3). 3) What are the cis regulatory elements that reinforce the pluripotent state (Project 3)? In our previous proposal we have identified numerous DNA cis regulatory modules (CRMs) and began to unravel RNA CRMs that guide nuclear localization. We now aim to functionally characterize the sequences and motifs within CRMs on a genome-wide scale (Project 2 and 3).

Public Health Relevance

Human pluripotent stem cells possess the ability to self renew in vitro while maintaining a developmental plasticity that is similar to that exhibited by progenitor cells of the very early embryo. As a result, pluripotent stem cells may provide an inexhaustible supply of any differentiated cell type for both in vitro studies of disease and regenerative medicine. Our program project overall objectives are to provide fundamental new insights into the mechanisms of cellular reprogramming and human pluripotency.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM099117-09
Application #
9959199
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Gibbs, Kenneth D
Project Start
2011-08-01
Project End
2022-03-31
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
9
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Harvard University
Department
Anatomy/Cell Biology
Type
Schools of Arts and Sciences
DUNS #
082359691
City
Cambridge
State
MA
Country
United States
Zip Code
02138
Pasque, Vincent; Karnik, Rahul; Chronis, Constantinos et al. (2018) X Chromosome Dosage Influences DNA Methylation Dynamics during Reprogramming to Mouse iPSCs. Stem Cell Reports 10:1537-1550
Charlton, Jocelyn; Downing, Timothy L; Smith, Zachary D et al. (2018) Global delay in nascent strand DNA methylation. Nat Struct Mol Biol 25:327-332
Maass, Philipp G; Barutcu, A Rasim; Weiner, Catherine L et al. (2018) Inter-chromosomal Contact Properties in Live-Cell Imaging and in Hi-C. Mol Cell 69:1039-1045.e3
Shukla, Chinmay J; McCorkindale, Alexandra L; Gerhardinger, Chiara et al. (2018) High-throughput identification of RNA nuclear enrichment sequences. EMBO J 37:
Maass, Philipp G; Barutcu, A Rasim; Weiner, Catherine L et al. (2018) Inter-chromosomal Contact Properties in Live-Cell Imaging and in Hi-C. Mol Cell 70:188-189
Ichida, Justin K; Staats, Kim A; Davis-Dusenbery, Brandi N et al. (2018) Comparative genomic analysis of embryonic, lineage-converted and stem cell-derived motor neurons. Development 145:
Maass, Philipp G; Barutcu, A Rasim; Shechner, David M et al. (2018) Spatiotemporal allele organization by allele-specific CRISPR live-cell imaging (SNP-CLING). Nat Struct Mol Biol 25:176-184
Melé, Marta; Mattioli, Kaia; Mallard, William et al. (2017) Chromatin environment, transcriptional regulation, and splicing distinguish lincRNAs and mRNAs. Genome Res 27:27-37
Smith, Zachary D; Shi, Jiantao; Gu, Hongcang et al. (2017) Epigenetic restriction of extraembryonic lineages mirrors the somatic transition to cancer. Nature 549:543-547
Merkle, Florian T; Ghosh, Sulagna; Kamitaki, Nolan et al. (2017) Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature 545:229-233

Showing the most recent 10 out of 62 publications